Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Pirillo

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
European Journal of Internal Medicine|July 26, 2025
Lipoprotein (a): A new target for pharmacological research and an option for treatmentAngela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|May 29, 2025
Beyond the mean: the prognostic value of lipid variability in atherosclerosis and mortalityAngela Pirillo, Alberico L Catapano
Current Cardiology Reports|April 21, 2015
Statin intolerance: diagnosis and remediesAngela Pirillo, Alberico Luigi Catapano
Circulation|July 19, 2021
Omega-3 for Cardiovascular Diseases: Where Do We Stand After REDUCE-IT and STRENGTH?Angela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|June 28, 2024
Proprotein convertase subtilisisn/kexin type 9 inhibitors: the earlier the better?Angela Pirillo, Alberico L Catapano
Disease Markers|November 8, 2013
Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseasesAngela Pirillo, Alberico Luigi Catapano
Expert Opinion on Biological Therapy|June 14, 2022
Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemiaAngela Pirillo, Alberico L Catapano
Current Atherosclerosis Reports|December 20, 2023
How to Handle Elevated Triglycerides: Life after PROMINENTAngela Pirillo, Alberico L Catapano
Current Atherosclerosis Reports|July 25, 2022
Inclisiran: How Widely and When Should We Use It?Angela Pirillo, Alberico Luigi Catapano
Atherosclerosis|November 2, 2015
Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studiesAngela Pirillo, Alberico Luigi Catapano
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Internal Medicine|July 26, 2025
Lipoprotein (a): A new target for pharmacological research and an option for treatmentAngela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|May 29, 2025
Beyond the mean: the prognostic value of lipid variability in atherosclerosis and mortalityAngela Pirillo, Alberico L Catapano
Current Cardiology Reports|April 21, 2015
Statin intolerance: diagnosis and remediesAngela Pirillo, Alberico Luigi Catapano
Circulation|July 19, 2021
Omega-3 for Cardiovascular Diseases: Where Do We Stand After REDUCE-IT and STRENGTH?Angela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|June 28, 2024
Proprotein convertase subtilisisn/kexin type 9 inhibitors: the earlier the better?Angela Pirillo, Alberico L Catapano
Disease Markers|November 8, 2013
Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseasesAngela Pirillo, Alberico Luigi Catapano
Expert Opinion on Biological Therapy|June 14, 2022
Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemiaAngela Pirillo, Alberico L Catapano
Current Atherosclerosis Reports|December 20, 2023
How to Handle Elevated Triglycerides: Life after PROMINENTAngela Pirillo, Alberico L Catapano
Current Atherosclerosis Reports|July 25, 2022
Inclisiran: How Widely and When Should We Use It?Angela Pirillo, Alberico Luigi Catapano
Atherosclerosis|November 2, 2015
Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studiesAngela Pirillo, Alberico Luigi Catapano
Pageof 12